A research team comprised of myself, Scott Sparrow, Remington Mallett, Josie Malinowski, and Mark Thurston is conducting a home-based research study that will test an enhanced lucid dream induction protocol.
The protocol consists of pre-sleep meditation, dream reliving, and the ingestion of the supplement galantamine––for the induction of lucid dreaming and the resolution of nightmares. This project builds upon a study recently published in Consciousness and Cognition, 63 (2018), 74-88 by members of team, which was the first peer-reviewed research to demonstrate the effectiveness of galantamine for lucid dream induction. The findings of that study also offered intriguing support for the specific use of the integrated protocol for nightmare resolution.
If you wish to participate in the study, we are looking for individuals who satisfy the DSM-5 criterion for Nightmare Disorder, moderate severity––that is, having two or more nightmares per week. However, if you do not fit the criteria and would still like to participate, we will be admitting participants who don’t fit that criterion., as well.
Because the study involves ingesting galantamine––and since galantamine can, on rare occasions, produce side effects––the Informed Consent form includes a statement attesting to the fact that you have ingested galantamine previously without incurring any deleterious side effects. If you have not used galantamine previously, you can still participate, but you will have to submit a letter from a physician approving you for the study.
Lastly – you must live in the United States to participate.
You can join the study by accessing the online Informed Consent/Background Survey at this link: Nightmare Resolution Study. It includes instructions about what is needed in the letter from your doctor, and where to fax the letter.
After we receive your Informed Consent/Background Survey (and letter, if needed), we will send you a research packet shortly thereafter.
The study has been approved by the IRB of the University of Texas Rio Grande Valley (IRB19-178), and has received funding from the International Association for the Study of Dreams in conjunction with DreamScience Foundation.